Monogram Health, a provider of virtual and in-person value-based in-home kidney and polychronic care services for millions of people in the United States, announced the closing of its $375 million new equity growth funding round.
Strategic investors CVS Health, Cigna Ventures, Humana, Memorial Hermann Health System, and SCAN led the investment round with participation from new and existing investors, including TPG Capital, Frist Cressey Ventures, Heritage Group, Pura Vida Investments, and Norwest Venture Partners.
More than 37 million American adults are living with chronic kidney disease, according to data provided by the company. In the press release, the company explained that the most recent funding enables it to expand its technology platform, which helps care providers deliver treatment (at scale) for millions of Americans with chronic kidney disease.
With new funds, Monogram Health also intends to speed up the deployment of its in-home kidney and polychronic care delivery model, as well as its technology-driven, evidence-based clinical services, which include complex case and disease management, utilization management, and medication therapy management.
Commenting on the funding news, Mike Uchrin, CEO and Co-founder of Monogram Health, said: “At Monogram Health we actively manage patients’ kidney disease and a wide range of acute and chronic conditions using our proprietary, evidence-based protocols and technology.”
“Everything we do is designed to improve access to health care and health outcomes for polychronic patients by supporting their individual needs in their own homes, transforming the patient experience, especially for those who have been historically underserved,” added Mike Uchrin.
Virtual healthcare startups
Telehealth companies have raised more than $40 billion in funding to date, according to our funding database. More recently, Carbon Health, a hybrid care company providing both telemedicine and in-person healthcare services for general chronic health conditions, raised $100 million in Series D funding from CVS Health Ventures, a corporate venture capital arm of CVS Health. In another deal, Doctor Anywhere, a telehealth startup providing virtual care for general health problems, raised $38.8 million in Series C funding led by Novo Holdings with participation from Asia Partners, Kamet Capital, Square Peg, IHH Healthcare, EDBI, and OSK-SBI Venture Partners.